Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Dr Amir Sam, Clinical Lecturer in Medicine, Imperial College London, and Specialist Consultant, Imperial College London Diabetes Centre, (ICLDC) was addressing delegates at the Middle East Diabetes Conference at Arab Health 2014.
He underlined new research which suggests how the drug Metformin, one of the most common treatments for type two diabetes, helps reduce the risk of developing and dying from some cancers.
Over the last few years some studies have suggested that Metformin inhibits pathways in the growth of cancerous cells.
http://www.abudhabicityguide.com/news/news-details.asp?newsid=14201&newstype=Local News
He underlined new research which suggests how the drug Metformin, one of the most common treatments for type two diabetes, helps reduce the risk of developing and dying from some cancers.
Over the last few years some studies have suggested that Metformin inhibits pathways in the growth of cancerous cells.
http://www.abudhabicityguide.com/news/news-details.asp?newsid=14201&newstype=Local News